← Eichor
Study identifier: NCT05358535 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Condition: Anesthesia · Propofol Adverse Reaction · Etomidate Adverse Reaction  ·  Sponsor: University of Texas Southwestern Medical Center

PhasePhase 3
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).

This description comes directly from the study's public registry record.

Talk to the study team

Christopher Choi  ·  2146486400  ·  christopher.choi@utsouthwestern.edu

Kapil Anand  ·  2146486400  ·  kapil.anand@utsouthwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Clements University HospitalDallas, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05358535